Simultaneous blockade of the HMGB1—TLR4 axis (e.g., via neutralizing antibodies) and the NLRP3 inflammasome (e.g., using MCC950) can decrease the secretion of IL—1β in experimental sepsis models. Here, TLR4 is linked to Sepsis.